Expression of Fibroblast Growth Factor 23, Vitamin D Receptor, and Sclerostin in Bone Tissue from Hypercalciuric Stone Formers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of Fibroblast Growth Factor 23, Vitamin D Receptor, and Sclerostin in Bone Tissue from Hypercalciuric Stone Formers

Published:2014-04-24 Issue:7 Volume:9 Page:1263-1270
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Menon Viviane Barcellos,Moysés Rosa Maria Affonso,Gomes Samirah Abreu,de Carvalho Aluizio Barbosa,Jorgetti Vanda,Heilberg Ita Pfeferman

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference50 articles.

1. New Insights Into the Pathogenesis of Idiopathic Hypercalciuria

2. Nephrolithiasis-associated bone disease: pathogenesis and treatment options

3. Bone disease in calcium stone forming patients.;Heilberg;Clin Nephrol,1994

4. Effect of Etidronate Treatment on Bone Mass of Male Nephrolithiasis Patients with Idiopathic Hypercalciuria and Osteopenia

5. Bone involvement in idiopathic hypercalciuria

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria;Clinical Kidney Journal;2023-11-01

2. Urinary Calcium Is Associated with Serum Sclerostin among Stone Formers;Journal of Clinical Medicine;2023-07-31

3. Interconnections between urolithiasis and oral health: a cross-sectional and bidirectional Mendelian randomization study;Frontiers in Medicine;2023-04-26

4. Vascular Calcification Is Associated with Fetuin-A and Cortical Bone Porosity in Stone Formers;Journal of Personalized Medicine;2022-07-10

5. Beta‐thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria;British Journal of Haematology;2022-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3